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Abstract
The larval zebrafish is emerging as a useful model to assess neurobehavioral toxicity. A
variety of behavioral assays have been developed to characterize normal behavior and the acute
and chronic effects of a variety of compounds. To date, such behavioral assays have been limited
to relatively simple behavioral measures (e.g., swimming activity in a single well). The present
experiment describes methodology to assess exploratory behavior in 5 days-post-fertilization (5
dpf) larval zebrafish using a six-chamber, complex well-plate. In addition, the effect of acute
nicotine exposure on exploratory activity in this complex environment was examined. Five dpf
TU strain larvae were studied. Larvae were treated with either 0, 16.25µM or 48.25µM nicotine
and were observed for 15 minutes. General Locomotor Activity, Zone Preference, Thigmotaxis
(outer zone preference), Thigmotaxis Path Type, Chamber Transitions, and Latency to enter the
Center Zone were measured using a Noldus tracking system. These results demonstrate (1) the
utility of this novel testing methodology, (2) that a low and high dose of nicotine increased
exploratory behavior in a complex environment and (3) dose-dependent behavioral changes due
to nicotine treatment, suggesting altered control of a specific type of exploratory behavior as
compared to a general increase in behavioral activation. These results while inconsistent with the
current literature on anxiety-driven behavior in other animal models may be explained by the
intrinsic properties of larval zebrafish behavioral phenotypes and molecular and cellular
differences in nicotinic receptor function.
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Introduction
Nicotine is a fascinating substance of study; it has been studied for its addictive potential,
but also for its potential neuroprotective and cognitive benefits—for patients with schizophrenia
and Parkinson’s disease. Many of the mechanisms by which nicotine affects cognitive abilities,
physiology, genetic expression, and behavior are unknown. The use of electronic cigarettes (ECigarettes), which allow for the inhalation of vaporized solution of nicotine and other chemicals,
has increased by nearly 800% from 2011 to 2014 (Arrazola et al. 2015). This has set a precedent
for gaining further insight into how nicotine affects cognition, physiology, and behavior.
Nicotine works through the activation and desensitization of nicotinic acetylcholine receptors.
These receptors are spread throughout the entire central nervous system affecting pathways for
GABA (Petzold et al. 2009), dopamine (Klee et al. 2011), norepinephrine (Klee et al. 2011),
serotonin (Papke et al. 2012), and glutamate (Papke et al. 2012). The ubiquitous affects of
nicotine on neurotransmission throughout the brain make it a difficult substance of study.
Common reasons for smoking among those who range from infrequent to frequent smokers
include the ability to reduce stress, increase cognitive function, habitual smoking and pleasure
(Hendricks & Brandon 2008). Because of the vast effect of nicotine on neurotransmission within
the CNS it is plausible to think that these benefits of smoking (i.e. anxiolytic & cognitive benefit)
can be molecularly and behavioral differentiated through the use of animal models. Research
using mammalian model systems (e.g. rats and mice) has demonstrated through genetic and
behavioral assays potential correlates of nicotine-induced benefit and nicotine-induced detriment
to the activation and desensitization of nicotinic receptors (Picciotto, Addy, Mineur, Brunzell
2008). For example, activation of the cholinergic-dopaminergic reward pathway through binding
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of nicotine to nicotinic acetylcholine receptors (nAChR) located on dopaminergic neurons has
been linked to the addictive properties of nicotine (McGranahan et al. 2011).
The neural pathways that nicotine effects in humans and rodents been are conserved in
zebrafish (Champagne et al. 2010; Richendrfer et al. 2012; Stewart et al. 2015). Therefore
zebrafish provide a high-throughput means of examining the neural pathways of nicotine
exposure as an extension of previous research conducted in mammalian models. The zebrafish
model affords the capability for 3D tracking (Cachat et al. 2011) of behavior. Furthermore, they
can exhibit a large variety of behavioral phenotypes compared to rodent models. Nicotine has
been a recent drug of interest in both mammalian and invertebrate models of anxiety as it has
been shown to increase exploratory behavior at low doses, have an anxiolytic, or anxietyrelieving, effect at higher doses, and an anxiogenic, or anxiety generating, effect when
chronically administered (Stewart et al. 2015; Lee 1985). This differential response to nicotine in
animals has also been demonstrated in humans (Haller et al. 2013; Connors et al. 2013; Belzung
& Philippot 2007).
Only recently has the adult zebrafish been used as a model for testing both anxiety and
the effects of nicotine using anxiety-testing paradigms (Levin et al. 2005; Levin et al. 2007,
Bencan & Levin 2008). Many of the behavioral assays used to test anxiety in mice such as the
open field test and the light-dark test—which will be explained later on—have been translated to
fit the zebrafish model. The validity of these designs in zebrafish have been confirmed through
the testing of pharmacological compounds previously tested in mammalian models and
commonly prescribed in humans (Stewart et a 2012; Richendrfer et al. 2012; Champagne et al.
2010; Blaser, Chadwick & McGinnis 2010). However, the use of zebrafish in the testing of
anxiety and anxiolytic and anxiogenic drugs has been limited to adult zebrafish. Only in recent
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years have larval zebrafish been used to test anxiety-related behaviors and nicotine (Petzold et al.
2009; Schnorr et al. 2012). These studies have shown that the larval zebrafish may be a viable
candidate in the screening of pharmacological compounds that affect anxiety, and that many of
the behavioral traits exhibited in mammalian and adult zebrafish models are conserved in larval
zebrafish (Schnorr et al. 2012). While there has been much researched published on anxiety and
animal models, much still has yet to be discovered about phenotypes of anxiety-related behavior.
It has been contested whether the current behavioral assays have the validity to be able to
translate into human pathological anxiety disorders, and whether the behavioral endpoints
commonly investigated are demonstrative of anxiety-related behaviors, or are rather
misinterpretations of behaviors motivated by stress, fear, or intrinsic behavioral properties of the
animal model. As it has become commonplace to use these behavioral markers of anxiety, it is
possible that what the current literature on anxiety has been describing is not in fact anxietyrelated behavior but rather activation of general exploratory behaviors. (Richendrfer et al. 2012;
Haller et al. 2013; Champagne et al. 2010; Blaser et al. 2010; Belzung & Philippot 2007; Stewart
et al. 2012). This is especially a concern in relatively simple behavioral assays in which an
animal is studied within a single arena. When investigating a drug such as nicotine that impacts
multiple neuronal pathways, using a single arena to investigate the behavioral alterations due to
drug treatment may lead to an increase likelihood to misinterpret different types of behavior.
2.1 Nicotine and Nicotinic Acetylcholine Receptors
The main mechanism of action of nicotine within the CNS is as a molecule that binds to
nAChRs (see fig 2). As was stated previously, these receptors can be found throughout the brain,
but the receptors to which nicotine has the highest binding affinity to are concentrated in the
dopaminergic reward pathway. nAChRs can be categorized as ligand-gated ion channels, which
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means that these receptors
act as pores within the
neuronal membrane, such
that once an agonist, such
as nicotine, binds to the
receptor surface, the pore
opens allowing the influx of
ions that can activate a
variety of mechanisms
thereafter having different
effects. Neuronal nAChRs

Figure 1 Illustrations of both
homomeric (top) and heteromeric
(bottom) nicotinic acetylcholine
receptors. Reprinted from (Davis
& de Fiebre 2006)

Table 1 Table of different subunits of
nAChRs, type of subunit, and example
nAChR compositions. Bolded lines indicate
known subunits to which nicotine typically
binds.

are pentamers of both α (α
2- α 10) and β (β 2- β 4)

subunits (see table 1), different combinations of these subunits, determine the type of ligand that
most efficaciously binds to the receptor, as well as the function of the receptor itself as an ion
channel. Nicotine acts as a partial receptor agonists (only partially activates the receptor) at all
heteromeric nAChRs, but is a full agonist (fully activates the receptor) for the α7 nAChR.
Furthermore, among the heteromeric nAChRs, nicotine binds most tightly to α4β2 receptor, found
most commonly on neurons within the dopaminergic reward pathway, and least tightly to
muscle-type receptors (Papke et al. 2012). While the α7 nicotinic receptor activation has been
implicated in cognitive benefits and neuroprotection in both Parkinson’s and Alzheimer’s disease
(Klee et al. 2011; Dome et al. 2010), activation of the α4β2 nAChR has been implicated in the
reinforcement of nicotine addiction and regulation of anxiety (Anderson & Brunzell 2012). The
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effects of nicotine are further
complicated by its role in the
desensitization of nAChRs (see
figure 2). Desensitization causes
the receptor to become “inactive.”
However, desensitization occurs in
Figure 2 Illustration of the different potential states of nAChR due to
nicotine. Reprinted from (“The Metabolism of Nicotine”)

only some nAChRs, and receptors

can become desensitized after acute exposure to nicotine (Picciotto et al. 2008). The activation
and desensitization of nicotinic receptors have implicated in the behavioral alterations due to
nicotine and the extent of activation and desensitization of nAChRs depend on the regimen of
nicotine exposure (Picciotto 2003). The alteration of nAChRs by nicotine in the
mesocorticolimbic system, specifically the cholinergic-dopaminergic pathway, has been
implicated to be responsible for a number of behavioral changes due to nicotine exposure.
2.2 Cholinergic-Dopaminergic Reward Pathway
The Cholinergic-Dopaminergic Reward pathway (see fig 3) is a neuronal pathway that is
conserved in both humans and other mammalian models such as rats and mice (Jerlhag & Engel
2011). While a homologous reward pathway of humans and mammals has yet to be identified in
zebrafish, some evidence suggests that nicotine similarly plays a role in the regulation of the
reward pathway in zebrafish as it does in mammals (Petzold et al. 2009). In mice, α4β2 nAChRs
have been observed to be active on dopaminergic neurons on substrates within the reward
pathway, the ventral tegmental area (VTA) and nucleus accumbens (NAc), such that expression
of α4β2 nAChRs on dopaminergic neurons is necessary for the observation of anxiolytic
responses observed after nicotine dosing (McGranahan et al. 2011). Specifically, desensitization
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the β2 subunit of
nAChRs of has been
implicated in generating
anxiolytic behavior in
mice (Anderson &
Brunzell 2012).
Furthermore, although
the reward pathway is

Figure 3 Illustration of the presence of different nAChRs in the human brain region. The
ventral tegmental area (VTA), the NAc (Nucleus Accumbens), and the PFC (prefrontal
cortex) are major substrates within the reward pathway. Hippocampus and Amygdala
are involved in memory and regulation of mood, respectively. Reprinted from (Feduccia,
Chatterjee, & Bartlett 2012)

commonly referred to as
the dopaminergic-

reward pathway, GABAergic and glutamatergic transmissions play a central role in the
regulation of dopaminergic transmissions and as nAChRs are present on GABAergic,
glutamatergic, and dopaminergic neurons (Pistillo, Clementi, Zoli, & Gotti 2015), nicotine
exposure can have a profound effect on specific locomotor behaviors regulated by the
dopaminergic-cholinergic pathway.
2.3 The Effect of Nicotine on Rodent
Behavior
Despite years of research, the
behavioral effects of nicotine on
rodents are still not well understood.
Rats dosed with nicotine behave
differently across different strains
Figure 4 Illustration of the effects of nicotine binding to an nAChR on a
dopaminergic neuron. Reprinted from (“Drugs Change the Way
Neurons Communicate”)

(Shoaib et al. 1997) gender (Torres et
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al. 2009), and ages (Levin et al. 2007). Furthermore, reduction in fear and anxiety and increase in
exploratory behavior in a novel environment has been shown to be dose-dependent, where higher
doses cause ataxia and decrease exploration in a novel environment, lower doses increase
locomotor activity (Clarke & Kumar 1983). This effect can be most accurately described as an
inverted-U dose response curve, where locomotor activity rises as dosage concentration increases
up until a certain point where the dosage causes a decrease in locomotor activity. With regards to
nicotine’s anxiolytic effect in rats, a primary behavioral measure of anxiety has been
thigmotaxis—the tendency for an animal to remain along the border of an enclosed, open field
arena (Cohen et al. 2009). Increased dopaminergic and noradrenergic and decreased serotonergic
neuronal activity may be responsible for the observed dose-dependent behavioral response to
acute exposure to nicotine in rats (Lee 1985). Furthermore, it has been suggested that
dopaminergic transmissions (see fig 4) can influence the exhibition of anxiety-like behavior such
that activation of D1 and D2 receptors resulted in an anxiogenic response in rats, but the
stimulation of only D1 or D2 receptors did not lead to an anxiogenic response (Simon, Dupuis, &
Costenin 1994). Moreover, acute nicotine administration in rats via intra-central amygdala (CeA)
injection induced an anxiogenic response, but blocking D1 and D2 receptors in the NAc and
VTA by administering a D1 and D2 receptor antagonist after nicotine administration antagonist
reduced the anxiogenic response (Zarrindast 2012, 2013). Although other measures have been
used to determine anxiety levels, thigmotactic behavior appears to be the most common marker
of anxiety across animal models, and is attenuated by dosing with anxiolytic compounds, such as
nicotine, or amplified by anxiogenic compounds. Furthermore, nicotinic receptor antagonists
such as mecamylamine have been shown to reverse the changes in nicotine-induced locomotor
behavior in rats (Clarke & Kumar 1983). The behavioral repertoire of both rats and mice have
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been translated and adopted to suite zebrafish (Champagne et al. 2010), a relatively highthroughput animal model recently developed to study the effect of nicotine on behavior.
2.4 The Effect of Nicotine on Adult Zebrafish Behavior
A variety of research has been conducted on anxiolytic compounds such as nicotine in
adult zebrafish, using thigmotaxis as the primary measure of anxiety-driven behavior (Blaser et
al. 2010; Levin et al. 2007). These studies have found that nicotine, indeed, has an anxiolytic
effect, in that overall thigmotactic behavior is reduced after both acute and chronic exposure to
nicotine. Similar to studies on their mammalian counterparts, adult zebrafish demonstrate an
attenuation of the anxiolytic effects of nicotine when also treated with nAChR antagonist,
mecamylamine (Levin et al. 2005). Akin to thigmotaxis, tank dwelling can serve as a
demonstration of anxiety-driven behavior in adult zebrafish such that anxiety causes zebrafish to
dwell in the bottom two-thirds of the test tank, and following treatment with nicotine, zebrafish
spend more time in the top 1/3 of the tank (see fig 7). Furthermore, anxiety-driven behavior has
been linked to involve both α7 and α4β2 nAChR such that treatment of adult zebrafish with
nicotine in addition to either α7 or α4β2 receptor antagonists will attenuate anxiolytic responses
(tank dwelling in the upper third portion and an increase in swimming speed) (Bencan & Levin
2008). However, further research is necessary to determine whether the activation of these
receptors result in the observed anxiolytic responses. Previous research has speculated that α7
receptor activation is linked to cognitive improvement, whereas α4β2 receptor activation may be
related to the reward pathway (Albuquerque, Pereira, Alkondon, Rogers 2008), it is possible that
the behavioral measurements employed in Bencan and Levin’s study (2008) were not specific
enough to distinguish between anxiety-driven behavior and changes in cognitive faculties.
Furthermore, while Levin’s studies focus on acute exposure to nicotine, Stewart et al. (2015)
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found that chronic nicotine exposure generates an anxiogenic behavioral response. Stewart’s
study utilized the same novel tank dive test as in Levin’s studies and found that after the fourth
day of exposure to low-dose nicotine, adult zebrafish began to exhibit typical anxiety-driven
behavior (i.e. tank dwelling, freezing bouts, and erratic movements). Similar to adult zebrafish,
larval zebrafish provide a potential model for the investigation of behavioral phenotypes linked
to nicotine exposure.
2.5 The Effect of Nicotine on Larval Zebrafish Behavior
Research using larval zebrafish provides the benefit of high-throughput capabilities,
which makes it an appealing animal model for drug screening tests and other behavioral assays.
Previous research that have studied the anxiety-driven behaviors in larval zebrafish have used
light-dark paradigm to promote anxiety (Schnorr et al. 2012) (see fig 6). This study provided a
framework for a thigmotaxis assay for the screening of drugs, and anecdotally provided evidence
that anxiolytic responses were observed in larval zebrafish given anxiolytic compounds. Through
the small area that is needed to work with larval zebrafish, it is easier to design mazes and open
fields that can more accurately test whether a behavior is anxiety-driven or being influenced by a
cognitive impairment/improvement or alterations in locomotor control. Furthermore, larval
zebrafish develop both nicotinic and dopaminergic neurons and respective receptors within the
first few hours post-fertilization. Complete set of dopaminergic neurons can be detected in larval
zebrafish by 8 days post-fertilization (Klee et al. 2011). Therefore, larval zebrafish should work
as a model organism for the study of the effects of nicotine on behavior and dopaminergic
pathways. Furthermore, larval zebrafish seem to demonstrate a similar dose-response curve as do
rats and adult zebrafish such that it follows an inverted-U shape, where doses higher than 100µM
reduce activity and there is a peak in activity around 50µM (Petzold et al. 2009). Potential
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confounds in using larval zebrafish is the difference in strain, gender, and age that were apparent
in the mammalian models of the effects of nicotine on behavior. There has been research that
suggests that locomotor activity is age dependent (Colwill & Creton 2011) within the larval
zebrafish age group such that larval zebrafish naturally demonstrate higher thigmotactic behavior
than their adult counterparts, and that larval zebrafish become significantly more active once
they reach 6 or 7 days post-fertilization (dpf) relative to 4 or 5 dpf zebrafish. However, larvae
begin to exhibit more complex behavior at 5 dpf (Colwill & Creton 2011). Therefore, it is
possible that these effects that were observed in the investigating of the effect of nicotine on rats
will be conserved in zebrafish.
2.6 Anxiety
Current animal based models of anxiety have attributed behaviors such as thigmotaxis as
representative of anxiety. For the most part, these studies have not differentiated anxiety from a
fear or stress response. While fear is the response to a present or imminent threat or danger,
anxiety is a fearful response to an upcoming or expected threat or danger. Although, homologous
neural structures that are responsible for the fear and anxiety response in humans have been
found in lower-order species such as rodents and fish (Belzung & Philippot 2007), current
behavioral assays rely on exploratory-driven anxiety-related paradigms in which an animal is
placed into a testing arena that has two general components a safe and a risky component. An
anxious reaction is thereby operationalized as the tendency to remain in the safe component as
opposed to the risky component. Therefore, an animal that has less anxiety would be more likely
to explore the risky component of the testing apparatus. Validation of these models has been
based on the efficacy of common human treatments of anxiety such as selective serotonin
reuptake inhibitors (SSRIs) and benzodiazepines (Cachat et al. 2010), and tests on genetic
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knockout strains of animals (McGrahanan et al. 2011). However, studies on animal anxiety using
traditional behavioral assays such as the open-field test or the elevated-plus maze, limit their
behavioral measures to traits such as thigmotaxis, freezing, increased latency to transition to the
risky component. While these behaviors have been noted in human studies of anxiety (Kallai et
al. 2007), in animal studies presence or absence of these behaviors may also be misconstrued
merely as a fear response or as an increase in exploratory behavior unrelated to the anxiety state
of the animal. One of the ways in correcting for potential misinterpretation of animal behavior
models of anxiety is through the development of new behavioral models of anxiety.
2.7 Neurotransmitter Pathways Involved in Anxiety
A variety of neurotransmitters have been implicated to regulate anxiety including, but not
limited to, dopamine, serotonin, GABA, and glutamate. The main treatments for anxiety in
humans are SSRIs, which inhibit the reuptake of serotonin within the brain, thus resulting in the
further stimulation of serotonergic receptors. The typical pharmacological compounds used in
animal models of anxiety are SSRIs, benzodiazepines, MAOIs, and nicotine. The behavioral
changes due to the administration of these drugs are examined in the following:
2.7.1 Anxiety: Humans
Anxiety in humans is correlated with dysregulation in the amygdala, subcortical
hippocampus, habenula, prefrontal and cingulate cortex (Belzung & Philippot 2007; Resller &
Mayberg 2007). These structures not only control the cognitive responses to anxiety, but also
somatic and behavioral responses (Lang, Davis, & Ohman 2000). The primary neurotransmitters
implicated in the activation of these responses are GABA, glutamate, serotonin and dopamine
(Bishop 2007). Drugs prescribed to treat anxiety in humans affect these neurotransmitter
pathways benzodiazepines (GABA), MAOIs (serotonin, dopamine), SSRIs (serotonin). Many of
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these drugs have been used in the study of anxiety using animal models. However, it is unknown
whether animals can experience anxiety in the same manner that humans can (Belzung &
Philippot 2007). Nevertheless, animal models have been used to attempt to understand the
behavior and genetic responses to anxiety.
2.7.2 Anxiety: Rodents
Rodents have been the most popular model to study anxiety-like behaviors and clinical
treatments for anxiety. The most typical behaviors measured in rodents as markers of anxietyrelated behavior include, but are not limited to thigmotaxis, erratic/avoidant behavior, freezing,
decreased tendency to interact with conspecifics. Similar neurotransmitters and neural substrates
have been implicated in rodent anxiety as human anxiety (Lee 1985; Zarrindast 2010, 2011,
2012, 2013). However, it has been debated whether current rodent models of anxiety are able to
correctly encapsulate pathological anxiety (Belzung & Philippot 2007). While part of this
skepticism is based on question of whether animals can experience anxiety in the human sense,
part is based on the simplicity of the current behavioral assays used in testing anxiety in
generating and differentiating anxiety-like behaviors from exploratory behavior. Similar issues
arise from other animal models such as the zebrafish, but the zebrafish have the potential to
exhibit a more complex variety of behaviors that may provide deeper insight into anxiety-related
behaviors in animal models.
2.7.3 Anxiety: Adult Zebrafish
As of recent, the adult zebrafish has been used as a model of anxiety. Although the neural
substrates that control anxiety-related behaviors in zebrafish are different than that in mammals,
homologous structures have been implicated (see fig 5). The habenula, which is thought to
control motor and cognitive aspects of fear-like behavior (Stewart et al. 2013), is regulated by
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dopaminergic and serotonergic neurons (Amo et al. 2010). Pharmacological studies have
demonstrated that dopaminergic, serotonergic, and GABAergic transmission has been implicated
in the regulation of anxiety-like behavior (Herculano & Maximino 2014; Champagne et al. 2010;
Maximino et al. 2010). The most commonly measured anxiety-related behaviors in adult
zebrafish are top and bottom preference, thigmotaxis, light and dark preference, erratic
movement, and freezing. Furthermore, the ability of the adult zebrafish model for 3D tracking of
behavior allows for a more complex classification of anxiety-behaviors and therefore yields the
potential to better differentiate anxiety-related behaviors from exploratory or fear motivated
behaviors. Similar to the adult zebrafish, the larval zebrafish is a viable candidate for future
studies of anxiety-related behaviors, as zebrafish larvae exhibit a similar behavioral repertoire to
rodent and adult zebrafish in measuring anxiety-related behavior.
2.7.4 Anxiety: Larval Zebrafish
While there have been few studies on
zebrafish larvae and anxiety-related
behavior. Current research has shown that
zebrafish larvae can exhibit anxiety-related
behavioral phenotypes such as thigmotaxis
(Schnorr et al. 2012), scototaxis
(Steenbergen et al. 2010), erratic and
freezing behavior (Kalueff et al. 2013).
Although the larval zebrafish have do not
Figure 5 Schematic of the sagittal brain sections of A) rat and B)
zebrafish habenular pathways. Red and blue represent medial
and lateral circuits, respectively. Reprinted from (Aizawa, Amo,
& Okamoto 2011)

have a fully established CNS until
approximately 8 dpf (Herculano &
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Maximino 2014), larvae are still capable of exhibiting anxiety-like behavior from 5 dpf
(Richendfrer et al. 2012). The testing of anxiolytic compounds has confirmed similar behavioral
effects on larvae as in rats and adult zebrafish (Richendrfer et al. 2012). The results of these
studies have suggested that the neurotransmitter pathways regulating anxiety-like behavior in
humans, rodents, and adult zebrafish seem to be conserved in larval zebrafish, thereby validating
their use as an animal model of anxiety. While rodents, adult zebrafish, and larval zebrafish have
the potential for expressing anxiety-related behaviors, interpretation of these behaviors are
limited by the behavioral assays used to study anxiety.
2.8 Different Behavioral Models of Anxiety
The most common behavioral assays for testing anxiety are the open field test and the
elevated-plus maze test (Haller, Aliczki, & Pelczer 2013). The open field test measures anxiety
mainly through thigmotaxis, the tendency to move along the outer areas of the open field. The
elevated-plus maze measures anxiety through the tendency of an animal to stay within the closed
arms of the plus maze and their avoidance of the open arms. These behavioral assays have been
mainly implemented in rodent models of anxiety. The following two behavioral assays: the lightdark test and the novel tank test are recent behavioral assays that have been established in adult
zebrafish as valid models to measure anxiety-related behaviors.
2.8.1 Light-Dark Test
In both adult and larval zebrafish the light-dark test has been shown as a novel way to
measure anxiety. Adult zebrafish demonstrate an innate avoidance of the light chamber and a
preference for the dark chamber (Stewart et al. 2010). Larval zebrafish demonstrate an innate
avoidance of the dark chamber and a preference for the light chamber (Steenbergen, Richardson
& Champagne 2011). The testing of anxiolytic compounds in juvenile zebrafish have been
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shown to alter this innate preference
(Steenbergen, Richardson, & Champagne
2011) such that anxiolytic compounds increase
the amount of time spent in the innately
avoided chambers (light for adult zebrafish;
dark for larval zebrafish). This behavioral
assay provides a unique measure of anxietyFigure 6 Schematic of light-dark test apparatus .
Reprinted from (Steenbergen, Richardson, & Champagne
2010)

related behaviors as it draws on innate
avoidance that may be more likely to draw on

anxiety processes than fear processes. It has further been suggested that the light-dark test
through pharmacological testing that different neural processes are modeled in the light-dark test
as opposed to the open field tests (Maximino et al. 2010). Furthermore, the novel tank test, an
adaptation of the open field test for adult zebrafish has been utilized to demonstrate that the adult
zebrafish is a capable organism for modeling anxiety-related behaviors.
2.8.2 Novel Tank Test
The novel tank test works on a similar
paradigm as the open field test, but instead
of inner and outer zones, the tank is split
into top and bottom zones. Adult zebrafish
have a preference to swim near the bottom
of the tank and avoid the top of the tank.
Preference to swim within the bottom
Figure 7 Schematic of Novel-Tank Test apparatus, dotted line
differentiates top from bottom portion of the tank

section of the tank has been suggested to
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be an anxiety response in adult zebrafish (Levin, Bencan, & Cerutti 2006; Stewart et al. 2010).
The testing of anxiolytic compounds on adult zebrafish in the novel tank test has been shown to
cause similar effects as rodents in the open field test. Therefore, this research suggests that adult
zebrafish may be used as a test of anxiety-related behaviors. However, the novel tank test faces
similar confounds in interpreting behavior as in the open field test for rodents. An increase in
exploratory behavior due to drug administration could be mistaken for a reduction in anxiety-like
behavior. Only recently has 3D tracking of adult zebrafish within the novel tank test have been
used to attempt to quantify more complex behaviors that may be able to differentiate these
behaviors and further characterize anxiety-related behaviors (Cachat et al. 2011). The utility of
the zebrafish to enable 3D tracking of behavior opens the possibility for the analysis of more
complex behaviors than capable with rodent models that are restricted to 2D tracking.
2.9 Utility of Using an Open Field Test in Measuring Anxiety
The open field test utilizes the innate avoidance of novel open spaces to measure anxiety.
Thigmotaxis, or the preference for the borders of an open field, is the main behavioral endpoint
measured to determine anxiety levels within animals (see fig 8). Potential problems in measuring
thigmotaxis in rats (Bouwknecht & Paylor 2008) have been translated into larval zebrafish
models as exemplified in the study conducted to test thigmotaxis in larval zebrafish (Schnorr et
al. 2012), such that thigmotactic behavior should not be calculated including low-moving or
unmoving animals. To correct for time spent not moving, thigmotaxis should be measured as
both a ratio of time spent in the outer zone and total duration of the trial and a ratio of distanced
moved in the outer zone and total distanced moved during the trial. These two variables can give
a more accurate description of thigmotactic behavior separate from individual preferences or
immobility in subjects. The testing apparatus used in a study conducted by Champagne and
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colleagues (2010), where the open field was
divided into several virtual square zones, and
locomotor activity was measured across each zone
provides greater complexity to the open field (see
fig 9). This design allows for the benefit of both
the open field and chambered tests such that
analyzing locomotor behavior in each zone may
Figure 8 Schematic of an open field test for
rodents, solid line represents physical borders of
the testing arena while dotted lines represent
virtual “inner zone”

be able to provide information on how
thigmotaxic behavior changes over time. Coupled
with pharmacological treatments, this type design
may provide insight into how different substances
may (in)activate different behavioral phenotypes.
This is especially useful when investigating the
behavioral effects of a substance such as nicotine
and complex anxiety-related behaviors.
2.10 Anxiety and Nicotine

Figure 1 Schematic of open field test for adult
zebrafish, outer borders represent physical
boundaries of the testing arena while the dotted lines
represent virtual “zones”, the “inner zone” represent
a virtual zone composed of the single box in the
middle

Acute nicotine treatment has been shown to
decrease anxiety in humans (Rose, Ananda &
Jarvik 2002), rodents (Lee 1985), adult zebrafish

(Levin et al 2007). In zebrafish larvae there is scant research on the anxiety reducing effects of
acute nicotine. Chronic nicotine, however, seems to have an anxiogenic effect on adult zebrafish
(Stewart et al. 2015). Nicotine affects dopaminergic, noradrenergic, and serotonergic,
GABAergic, and glutamtergic pathways in areas implicated in the modulation of anxiety. Acute
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nicotine administered to rodents decreased serotonin turn-over rate, increased dopaminergic and
noradrenergic activity (Lee 1985). The effect of nicotine on behavioral responses has been
shown to be dose-dependent such that higher doses are anxiolytic, while lower doses increase
exploratory behavior (Lee 1985). However, may affect anxiety differently than common
prescription anxiolytics as they indirectly affect these neurotransmitters through activation and
desensitization nAChRs (Picciotto 2003). Furthermore, as nicotine has a widespread affect of
neurotransmitter pathways in different neural substrates, it is likely that nicotine can modulate
different types of behavior. Therefore, in behavioral studies using nicotine it is important to be
able to differentiate anxiety-related behaviors from exploratory behaviors and potential cognitive
affects of nicotine that may be influencing the interpretation of behaviors in animal models.
2.11 Confounds in Interpreting Anxiety-related Behavior
Behavioral models developed for rodents and adult zebrafish have attempted to encapsulate
anxiety-related behaviors. Different behavioral endpoints have been measured to attempt to
differentiate anxiety-related behaviors from the activation of other behavioral phenotypes.
However, many of the traditional models such as the open-field test/novel-tank test, are still
limited in the types of behaviors that can be measured to differentiate activation of anxietyrelated behaviors from normal exploratory responses. The current behavioral assays for larval
zebrafish are currently limited to analyzing behavior in a single arena. In the evaluation of
anxiety-related behaviors this does not suffice as, it increases the possibility of misinterpreting
behavioral endpoints associated with anxiety. While these behavioral assays and behavioral
endpoints have been partially validated by the testing of anxiolytic and anxiogenic compounds, it
remains unclear whether these assays induce enough anxiety to produce anxiety-related
behaviors (Blaser et al. 2010), model pathological anxiety (Prut & Belzung 2003) and whether
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these behavioral endpoints are sufficient to characterize anxiety within these animal models
(Simon et al. 1994; Prut & Belzung 2003). Therefore the present study attempts to outline a
novel behavioral assay that may be able to provide a deeper understanding of effects of acute
nicotine on exploratory behavior in larval zebrafish.
This project aims to: 1) determine the validity of a new 6-chamber complex environment
as a new behavioral assay for testing exploratory and anxiety-related behavior in larval zebrafish;
2) propose a refinement of currently accepted behavioral endpoints of anxiety-related behavior
such as thigmotaxis; 3) support the use of larval zebrafish as an animal model for future anxiety
research; 4) determine whether the effects of nicotine on larval zebrafish can be 5) correlated
with anxiety-related behavior or 6) whether nicotine explicitly activates exploratory behavior.
Methods
3.1 Fish Husbandry
Male and female adult zebrafish (danio rerio) of Tu strain were used to obtain fertilized
zebrafish eggs for testing. Fish were kept on a 14 h light: 10 h dark cycle. Water and air
temperature were maintained at 28°C. Male breeders were kept in tanks with maximum of 2 fish
while females were kept in tanks with a maximum of 4 fish. Fish were fed twice daily—once
with dry food and the once with brine shrimp.
Zebrafish eggs were obtained by mating predetermined pairs of males and females.
Matings were set up overnight and embryo collection and processing was conducted the day after
approximately 1 hour after the onset of lights. Matings pairs were set up on alternate days to
ensure that no pair was set up on consecutive days.
Embryos were first collected and then cleaned using a bleach solution, washed out, and
then transferred to a petri dishes filled with sterilized rack water (egg water) (60µg/mL Instant
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Ocean (Spectrum Brands)). Embryos were housed at a temperature of 28°C under the same darklight cycle as the adult zebrafish. Upon 5 dpf, zebrafish were moved to the testing location and
were allowed to acclimate to the new room for at least 1 hour prior to testing.
3.2 Testing Apparatus: Two 6-Chamber Complex Environments

Figure 10 Schematic of two 6-Chamber Complex Environments. A single 12-well plate creates two testing arenas; outer
zone and inner zone are delineated as well as the depth and width of the transition portion. “*” Indicates the start zone in
both testing arenas.

A 12-well plate (Corning Inc., Corning, New York) (well diameter: 22.7mm) was made
into the 6-chamber complex environment by melting the area in between wells with a soldering
iron to create a leak-proof channel for movement. The 12-well plate was shaped to form 2 6chamber complex environments (see fig 10). The environment was designed to measure the
locomotor behavior of a single zebrafish larvae within a single environment. Using suggestions
by (Schnorr et al. 2012) the 12-well plate was chosen to serve as the testing apparatus as the
length of the delineated inner and outer zones of each chamber was larger than the length of an
average larval zebrafish. Inner and outer zones were determined such that the spatial area of the
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inner zone would be approximately equivalent to the other zone thereby ruling out potential
biases in zone preference due to differences in zone size.
3.3 Experimental Procedure
Zebrafish were allowed to acclimate to the testing room’s temperature for at least 1 hour
prior to testing with the lights on
while still in the petri dish. The
testing apparatus was moved to the
well-plate holder and filled with the
testing solution (egg water, 16.25µM
nicotine, or 48.75µM nicotine).
48.75µM of nicotine were decided
based on observed maximum
locomotor activity response to acute
exposure to ~50µM nicotine in a
study conducted by Petzold and
Figure 11 Schematic of experimental set-up. LEDs backlight the testing
apparatus, while a camera fitted with an infrared lens tracks larval
zebrafish movement. Adapted from (Ahmad & Richardson 2013)

colleagues (2009). 16.25µM was

chosen because it was a threefold reduction in concentration of the high dose of nicotine.
Zebrafish were then transferred to the testing arena (one per environment) through a plastic
pipette. Minimal maneuvering of the zebrafish larvae was attempted to reduce potential stress
induced by aspirating and transfer. Larvae were placed in the same relative position within the
border zone of the well. Upon placement in the well, the room lights were turned off and the
automated video-tracking began. All larvae were tracked using Ethovision XT 8.5 (Noldus,
Wageningen, Netherlands) (see fig 11). The testing apparatus was lit by infrared LEDs (890nm)
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(Jameco, Bellemont, CA) and recording using an Ikegami digital camera (model no. ICD-49)
(Ikegami Tsushinki Co., Ltd., Tokyo, Japan) with a Nikon Micro-Nikkor 55mm lens attachment
(Nikon Co., Tokyo, Japan). Maximum darkness was ensured through the use of infrared
detection methods. Larvae were tracked for 15 minutes and then removed from the testing arena
and placed in a separate petri dish for later euthanasia through tricaine overdose and disposal. No
larvae were used twice for any of the experiments. When changing the solution within the testing
arena, the well-plate was removed from the holder and the well-plate was thoroughly rinsed and
dried before it was refilled with the new solution. The same volume of solution was maintained
throughout the trials to prevent any effect of water levels on the ability of the larvae to transition
from chamber to chamber.
3.4 Dosing and Drug Administration
Nicotine was chosen for its demonstrated anxiolytic properties in humans and rodents, as
well as zebrafish (Levin et al. 2005). A low dose and high dose of nicotine were used to attempt
to determine whether there was a dose-dependent effect of nicotine on thigmotaxic and
exploratory behavior within the testing environment. Nicotine solutions were prepared by
dissolving 23.5mg of nicotine di-tartrate salt (Sigma Aldrich, St. Louis, MO) (MW 498) in 50mL
of sterile egg water to achieve an 1mM of nicotine di-tartrate stock solution, the stock solution of
nicotine was then further diluted in egg water to achieve a 16.25µM and 48.75µM dose of free
base nicotine. Larvae were exposed to the drug solution throughout the trial period (15min).
Excess egg water from the petri dish was minimized during transfer of the larvae to the testing
arena to prevent gross changes in the concentration of the drug solution.
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3.5 Behavioral Endpoints
All locomotor activity was automatically recorded and video files were saved for later
editing (to fill in missing simples or incorrect tracking). The behavioral endpoints reported in this
study include, total distanced moved (mm), zone preference
(measured as time spent and distance moved), thigmotaxis as
described in Schnorr et al. (2012): ratio between total
distanced moved in outer zone of a given chamber and total
distanced moved within the same chamber and the ratio of the
total time spent in the outer zone of a given chamber and the
total time spent within that same chamber, thigmotaxis type
(see fig 3) as described in Creed & Miller (1990), latency to
first enter center zone(s), and frequency of chamber
transitions. As this experiment employs a novel 6-chamber
Figure 12 Illustration of potential
types of thigmotaxis within the 6chamber complex environment. Path
A represents passive thigmotaxis; path
B presents weakly active thigmotaxis,
path C represents active thigmotaxis

complex environment, zone preference, thigmotaxis, latency
to enter the center zone, and chamber transitions were
measured across the 6 chambers that may have been explored

by the larvae. Furthermore, to investigate the temporal changes in behavior, general locomotor
activity was analyzed within 1-minute bins (total 15 bins), and chamber transitions were
analyzed within 5-minute bins (total 3 bins).
3.6 Statistical Analysis
Statistical analyses were performed using SPSS (version 23). Total distanced moved was
analyzed using a one-way ANOVA for comparisons of the effect of nicotine treatment. Zone
preference was analyzed using student’s t-tests. Thigmotaxis measures (time spent & distance
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moved) and thigmotaxis type were analyzed using one-way ANOVAs. Overall chamber
transitions were analyzed using a one-way ANOVA. Frequency of chamber transitions per
chamber was analyzed using a MANOVA. Latency to enter the center zone data was analyzed
using one-way ANOVAs and student’s t-tests. Time binned data (for general locomotor activity
& chamber transitions) was analyzed using a mixed ANOVA. Tukey HSD post-hoc tests were
run to determine group-specific effects of drug treatment. Simple effects tests were run with
bonferroni corrections to further interpret significant interactions. Graphs were created using
excel and data was presented as means ± SEM. The criterion for significance was set at a
probability of 5%.
Results

Figure 13 Sample tracks from experiment. A) Track from CON; B) Track from a 16.25µM nicotine treated larvae; and C)
track from a 48.75µM treated larvae. Tracks shown outline the movement of a larvae throughout the 15-minute trial
duration
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4.1. General Locomotor Activity
Locomotor activity was assessed by examining total distance moved for the duration of
the 15-min trial and by time using one-minute bins.
4.1A Overall Locomotor Activity
There was an effect of treatment
condition on general locomotor
activity (see fig 14), a one-way
ANOVA F(2,148)=18.11, p<0.05
revealed that larvae treated with
16.25µM of nicotine (LNIC)
(2017.32±129.5) moved
Figure 14 General locomotor activity was measured as the total distance
moved throughout the 15 minute trial. Bars represent mean±SEM for each
treatment condition

significantly more than egg water
treated larvae (CON)

(1182.25±93.2). Similarly, larvae treated with 48.75µM of nicotine (HNIC) (2342.75±181.98)
moved significantly more than CON (1182.25±93.2), p<0.05. There was no significant
difference observed between LNIC and HNIC. These results demonstrate that acute nicotine
treatment increases locomotor activity in larval zebrafish.
4.1B General Locomotor Activity Over Time
Total distance moved was measured in larvae over one-minute bins (see fig 15). Mixed
ANOVA revealed a significant main effect of time F(14,143)=40.353, p<.05, and a significant
main effect of treatment F(2,143)=17.72, p<.05. CON moved less than both the LNIC and
HNIC, p<0.05 and p<0.05, respectively. There were no observed differences between the two
nicotine conditions. There was a significant time by treatment condition interaction

26

EFFECTS OF ACUTE NICOTINE ON LARVAL ZEBRAFISH

27
F(28,143)=10.47,
p<0.05. Simple
effects tests
comparing the first
and last time bin
revealed that CON
distance moved did
not change over time

Figure 12. General locomotor activity over 15 1-minute bins (15 minutes). Data points
represent average distanced moved within the time bin, mean±SEM.

(1st minute:

59.918±14.23) (15th minute: 71.356±9.26), but both nicotine treatment groups distance moved
decreased significantly LNIC (1st minute: 219.918±14.37) (15th minute: 69.29±9.36) p<0.05, and
HNIC (1st minute: 230.07±14.23) (15th minute: 105.31±9.26), p<0.05.
Comparing the distanced moved of larvae treatment groups at the first and last minute of
the trial showed that at the 1st minute CON (59.918±14.23) moved significantly less than LNIC
(219.918±14.37) and HNIC (230.07±14.23), p<0.05 and p<0.05, respectively. LNIC did not
significantly differ from HNIC. At the 15th minute CON (71.356±9.26) did not significantly
differ from LNIC (219.918±14.37), but CON and LNIC moved significantly less than HNIC
(230.07±14.23), p=0.032 and p=0.021, respectively. These results suggest that both low dose and
high dose nicotine cause larvae to move more within the first few minutes of the test compared
to CON, but locomotor activity decreases over time in both nicotine treatment groups. Lastly, by
the end of the trial HNIC exhibited more locomotor activity than both CON and LNIC.
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4.1C Summary of General Locomotor Activity
Nicotine, regardless of the strength of the dose, increased larvae locomotor activity.
Furthermore, nicotine increased larval activity during the beginning of the trial relative to CON,
but by the end of the trial, LNIC demonstrated the same amount of general activity as CON.
Moreover, HNIC increased general activity in larvae relative to LNIC and CON by the end of the
trial. The activity of both LNIC and HNIC decreased over the duration of the trial. In sum,
nicotine seems to increased general locomotor activity overall, but only HNIC increased general
locomotor activity from the beginning to the end of the trial.
4.2 Zone Preference: Distance Moved & Time Spent (DM & TS)
Inner versus Outer Zone Preference (IOZP) was measured by both distanced moved
(DM) and time spent (TS) in outer and inner zones of each chamber. Overall zone preference
was measured by averaging the IOZP across each of the six chambers. The purpose of analyzing
zone preference using both distanced moved and time spent in each zone parameters is to
determine the validity of both of these measures as compared to previous literature and the
consistency between the two measures.
4.2.1A Zone Preference: Distance Moved (DM)
IOZP was calculated as the percent of the total distance spent in either the outer or inner
zone throughout the 15-minute trial.
𝐼𝑂𝑍𝑃   %  𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒𝑑  𝑀𝑜𝑣𝑒𝑑  𝑖𝑛  𝑍𝑜𝑛𝑒 =

!"#$%&'()  !"#$%  !"  !"#$%  !"  !""#$  !"#!
!"#$%  !"#$%&'()  !"#$%  !"  !!!"#$%

×100

4.2.1B Overall Zone Preference
All treatment groups demonstrated a significant preference for the outer zone throughout
the 15-minute trial (see fig 16A). CON exhibited a preference for the outer zone (65.88±1.78)
compared to the inner zone (34.12±1.78), t(48)=8.91, p<0.05. LNIC exhibited an outer zone
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preference (70.75±1.33) compared to the inner zone (29.25±1.33), t(49)=15.53, p<0.05. Finally,
HNIC showed an outer zone preference (64.35±1.42) compared to the inner zone (35.64±1.42),
t(49)=10.10, p<0.05. This
data suggests nicotine at
both high or low doses
did not have an effect on
outer zone preference.
4.2.1C IOZP: Per
Chamber
Across all treatment
groups, larvae
demonstrated a higher
proportion of outer zone
preference across the 6
chambers of the testing
arena (see table 2).
Chambers in which not
enough subjects entered
(n<5) were excluded from
Figure 16 & Table 2 A) Overall Zone Preference; B) Zone Preference of controls; C)
Zone Preference of low nicotine group; D) Zone Preference of high nicotine group,
data presented as mean±SEM. Table represents means±SEM for outer and inner zone
preference in all chambers “*” Indicates not enough fish entered the chamber for an
accurate measure of zone preference. Discrepancies between degrees of freedom
between total time spent and total distanced moved measures of zone preference can
be attributed to low/unmoving larvae within the chamber. N=no observed preference,
O=preference for outer zone, I=preference for inner zone

statistical analysis. CON
larvae demonstrated an
outer zone preference in
chambers 1, 2, 3 and 4

EFFECTS OF ACUTE NICOTINE ON LARVAL ZEBRAFISH

30

(see fig 16B). LNIC larvae similarly exhibited an outer zone preference in all chambers 1-6 (see
fig 16C). HNIC larvae demonstrated an outer zone preference in chambers 1, 2, 3, 5, and 6 (see
fig 16D). Together this data suggests that outer zone preference is generally conserved in
nicotine treated subjects.
4.2.1D Summary of Zone Preference (DM)
Nicotine at either high or low doses does not seem to change the outer zone preference of
larval zebrafish. The effect of nicotine on zone preference will further examined in the analysis
of thigmotaxis. In order to determine whether this finding is reliable, zone preference as
measured by time spent in outer and inner zones was analyzed as well.
4.2.2A Zone Preference: Time Spent (TS)
Zone preference was also determined by the amount of time each subject spent within
either the outer zone or the inner zone. Time spent was reported as a percentage of the time spent
in the chamber.
𝐼𝑂𝑍𝑃  (%  𝑇𝑖𝑚𝑒  𝑆𝑝𝑒𝑛𝑡  𝑖𝑛  𝑍𝑜𝑛𝑒) =

!"#$  !"#$%  !"  !"!"#  !"  !""#$  !"#$
!"#$%  !"#$  !"#$%  !"  !!!"#$%

×100

4.2.2B Overall Zone Preference
All treatment groups demonstrated a significant preference for the outer zone throughout
the 15-minute trial (see fig 17A). CON exhibited a preference for the outer zone (71.22±2.27)
compared to the inner zone (28.78±2.27), t(48)=9.34, p<0.05. LNIC exhibited an outer zone
preference (80.89±1.35) compared to the inner zone (19.10±1.35), t(49)=22.80, p<0.05. Finally,
HNIC exhibited an outer zone preference (77.17±1.72) compared to the inner zone (22.83±1.72),
t(49)=15.78, p<0.05. This confirms the findings from the zone preference (DM) (section 4.2.1AD) that subjects prefer the outer zone between treatment groups.
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4.2.2C IOZP: Per Chamber
Larvae across all treatment groups demonstrated a higher outer zone preference across
the 6 chambers of the testing arena (see table 2). Chambers in which not enough subjects entered
(n<5) were excluded
from statistical analysis.
CON demonstrated a
higher outer zone
preference in chambers
1, 2, 3, and 6 (see fig
17B). LNIC
demonstrated a higher
outer zone preference in
chambers 1, 2, 3, 5, and
6 (see fig 17C) HNIC
demonstrated a higher
outer zone preference in
chambers 1, 2, 3, 5, and
6 (see fig 17D). While
this data does not
Figure 17 & Table 3 A) Overall Zone Preference; B) Zone Preference of controls; C)
Zone Preference of low nicotine group; D) Zone Preference of high nicotine group, data
presented as mean±SEM. Table represents means±SEM for outer and inner zone
preference in all chambers “*” Indicates not enough fish entered the chamber for an
accurate measure of zone preference. Discrepancies between degrees of freedom between
total time spent and total distanced moved measures of zone preference can be attributed
to low/unmoving larvae within the chamber. N=no observed preference, O=preference
for outer zone, I=preference for inner zone

exactly match zone
preference (TDM), it is
generally consistent
with the observation that
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larvae treated acutely with nicotine still prefer the outer zone to the inner zone.
4.2.2D Summary of Zone Preference (TS)
Larval zone preference as measured by the time spent in the outer and inner arena
confirms that larvae prefer the outer zone of a chamber even when treated with low dose or high
dose nicotine. These results are mostly consistent with the findings from section 4.2.1A-D. Outer
zone preference (thigmotaxis) will be compared between groups to determine to what extent
nicotine effects IOZP.
4.3 Thigmotaxis
Thigmotaxis (outer zone preference) was measured as percent total distance moved and
percent total time spent in the outer zone across all treatment groups. Overall and per chamber
thigmotaxis was analyzed.
4.3.1A Thigmotaxis (DM)
!"#$%&'()  !"#$%  !"  !"#$%  !"#$

𝑇ℎ𝑖𝑔𝑚𝑜𝑡𝑎𝑥𝑖𝑠  (%  𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒𝑑  𝑀𝑜𝑣𝑒𝑑  𝑖𝑛  𝑂𝑢𝑡𝑒𝑟  𝑍𝑜𝑛𝑒) = !"#$%  !"#$%&'()  !"#$%  !"  !!!"#$% ×100
4.3.1B Overall Thigmotaxis
Overall thigmotaxis was calculated by averaging the amount of thigmotaxis observed (%
total distance moved in the outer
zone) across all chambers (see fig
18). ANOVA revealed a significant
main effect of treatment on
thigmotaxis F(2,146)=4.84,
p=0.009. There were no observed
significant differences between
Figure 18 Overall thigmotaxis depicted as mean±SEM across all 6
chambers of the testing arena

CON and LNIC or HNIC, but
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LNIC larvae exhibited significantly more thigmotaxic behavior than HNIC larvae.
4.3.1C Thigmotaxis: Per Chamber
Thigmotaxis was also examined
across individual chambers of the
maze between all treatment
groups (see fig 19 and table 4). In
chamber 1, LNIC increased
thigmotaxic behavior relative to
CON whereas HNIC showed no
difference from CON. There was
no observed significant
difference between treatment
groups in the 2nd chamber. In the
3rd chamber HNIC decreased
thigmotaxic behavior relative to
Figure 19 & Table 4 Thigmotaxis (DM) within each chamber across
treatment groups. Bars represent mean±SEM. Table shows mean±SEM of
thigmotaxis for each chamber across treatment groups, ns indicate non
significance; “+” indicates significantly greater than; “-” indicates
significantly less than; and “/” indicates non-significance

both LNIC and CON. Within the
4th chamber, HNIC larvae
exhibited less thigmotaxis

relative to LNIC larvae, but not CON. There were no significant differences in thigmotaxis
behavior in the 5th or 6th chambers.
4.3.1D Summary of Thigmotaxis (DM)
Within this 6-chamber complex environment, thigmotaxis, which is typically used as a
measure of anxiety-like behavior, appeared to be affected by nicotine treatment, such that LNIC
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treated larvae exhibit higher thigmotaxis than HNIC larvae (chambers 3, 4, and overall), and
CON (chamber 1). Furthermore, HNIC larvae demonstrate decrease thigmotaxis than CON
(chamber 3). This suggests that HNIC potentially decreases thigmotaxic behavior, while LNIC
increases thigmotaxic behavior. Thigmotaxis as measured by time spent in the outer zone of a
given chamber was measured to determine the consistency of the thigmotaxis (DM) results.
4.3.2A Thigmotaxis (TS)
𝑇ℎ𝑖𝑔𝑚𝑜𝑡𝑎𝑥𝑖𝑠  (%  𝑇𝑖𝑚𝑒  𝑆𝑝𝑒𝑛𝑡  𝑖𝑛  𝑂𝑢𝑡𝑒𝑟  𝑍𝑜𝑛𝑒) =

!!"#  !"#$%  !"  !"#$%  !"#$
!"#$  !"#$%  !"  !!!"#$%

×100

4.3.2B Overall Thigmotaxis
Overall thigmotaxis was measured as the amount of time spent in the outer zone across
all chambers within the testing
apparatus (see fig 20). There was
a significant effect of nicotine
treatment on thigmotaxis
F(2,148)=7.193, p=0.001. Post
hoc tests revealed that CON
(71.21±2.27) larvae exhibited
significantly less thigmotaxis
Figure 20 Overall thigmotaxis depicted as mean±SEM across all 6 chambers of
the testing arena

than the LNIC (80.89±1.35)

larvae p=0.001, but not the HNIC larvae (77.16±1.72). These results suggests that LNIC
increases thigmotaxic behavior overall within the 6-chamber complex environment.
4.3.2C Thigmotaxis: Per Chamber
Thigmotaxis per chamber was also examined (see fig 21 and table 5). Within the 1st
chamber both LNIC and HNIC larvae exhibited more thigmotaxis relative to CON. There was no
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observed difference in
thigmotaxis between the two
nicotine treatments. In the 2nd
chamber, only LNIC larvae
exhibited higher thigmotaxis
relative to CON. Again, there
were no observed differences in
thigmotaxis between the two
nicotine treatments. There was no
effect of nicotine treatment on
thigmotaxis within the 3rd, 4th,
and 5th chambers. Lastly, there
was a significant effect of
Figure 21 & Table 5 Thigmotaxis (TS) within each chamber across treatment
groups. Bars represent mean±SEM. Table shows mean±SEM of thigmotaxis
for each chamber across treatment groups, ns indicate non significance; “+”
indicates significantly greater than; “-” indicates significantly less than; and
“/” indicates non-significance

nicotine treatment on thigmotaxis
within the 6th chamber such that
LNIC larvae exhibited

significantly more thigmotaxis than HNIC, but not CON. There were no observed differences in
thigmotaxis between both nicotine treatments and CON.
4.3.2D Summary of Thigmotaxis (TS)
Thigmotaxic behavior as measured by time spent in the outer zone did not fully
corroborate the results from thigmotaxis (DM) (section 4.3.1A-D). LNIC larvae exhibited more
thigmotaxis than CON both overall and within chambers 1 and 2. HNIC larvae demonstrated
more thigmotaxis than CON in the 1st chamber, and demonstrated less thigmotaxis than LNIC
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larvae in the 6th chamber. While the statistical analyses did not demonstrate a significant
anxiolytic effect of HNIC the average amount of thigmotaxis expressed by HNIC larvae is
generally lower than both LNIC and CON (see table 5). It is possible that there were not enough
larvae that entered the further away chambers (3-5) to demonstrate a significant result.
Nevertheless, this data demonstrates that low dose nicotine increased thigmotaxic behavior in
larvae, while high dose nicotine does not seem to have a significant effect on thigmotaxis as
measured by time spent in the outer zone of a chamber.
4.4. Thigmotaxis Type
The frequency of occurrence of three different types of thigmotaxis (active, passive,
weakly active) was measured
(see fig 22). An ANOVA
revealed that nicotine
treatment had a significant
effect on active
F(2,148)=9.43, p<0.05 and
weakly active F(2,148)=19.41,
Figure 22. Thigmotaxis path types were measured as frequency of occurrence.
Bars represent manually scored data, mean±SEM. Common letters denote nonsignificance.

p<0.05 thigmotaxis, but not
passive thigmotaxis. For

active thigmotaxis, post hoc tests revealed that CON (0.39±0.10) and HNIC (0.92±0.16) larvae
exhibited less active thigmotaxis than LNIC (1.58±0.27) larvae, p<0.05 and p=0.045,
respectively. Furthermore, CON (0.92±0.22) exhibited significantly less weakly active
thigmotaxis than both LNIC (5.14±0.67) and HNIC (3.4±0.43) larvae, p<0.05 and p=0.001,
respectively. LNIC larvae exhibited significantly more weakly active thigmotaxis than HNIC
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larvae, p=0.030. These results demonstrate that nicotine greatly increases active and weakly
active thigmotaxic behavior, but has no effect on passive thigmotaxic behavior.
4.4A Summary of Thigmotaxis Path Type
These results suggest that LNIC and HNIC increased the tendency of the larvae to engage
in both active and weakly active thigmotaxis, while having no effect on the frequency of passive
thigmotaxis. Specifically, LNIC increased active and weakly thigmotaxic behavior relative to
both HNIC and CON. HNIC only increased weakly active thigmotaxis relative to CON. Active
thigmotaxis is a more accurate descriptor of anxiety within animals, while passive thigmotaxis
does not describe anxiety-like behavior. Weakly active thigmotaxis can be interpreted as anxietylike behavior, but is demonstrative of a weaker anxiety level in the larvae. Taken this way, then it
seems that LNIC and to a lesser extent HNIC increases anxiety in larval zebrafish.
4.5. Chamber Transitions
Chamber transitions were measured as the number of times larvae moved from one
chamber to an adjacent chamber. Chamber transitions were measured overall, per chamber, and
overall transitions over one minute time bins.
4.5A Overall Chamber
Transitions
Overall chamber transitions
were measured across the
treatment conditions (see fig
23). An ANOVA revealed a
significant effect of nicotine
Figure 23 Overall chamber transitions represented as mean±SEM averaged
across all 6 chambers.

treatment on the frequency of
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chamber transitions F(2,148)=19.18, p<0.05, such that both LNIC (8.26±0.98) and HNIC
(5.42±0.731) larvae transitioned significantly higher than CON (1.81±0.315) larvae, p<0.05 and
p=0.002,
respectively.
Furthermore,
LNIC larvae
transition
significantly more
than the HNIC
larvae, p=0.019.
This suggests that a LNIC motivates
more chamber transitions in larval
zebrafish relative to CON and HNIC
treatment.
4.5B Chamber Transitions: Per
Chamber
Chamber transitions per chamber were
calculated based on the frequency of
transitions across chambers. Transitions
in and out of a given chamber were
measured separately. i.e chamber
transition from chamber 1 to chamber 2
Figure 24. Chamber transitions MANOVA depicted, letters with “*”
denote significance. Letters E (CON), L (LNIC) and H (HNIC) denote
treatment conditions.

was measured as different from a
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chamber transition from chamber 2 to chamber 1 (see fig 24). A MANOVA revealed a
significant effect of nicotine treatment on chamber transitions Wilks’ Lambda=0.690,
F(20,274)=2.793 p<0.05. Specifically, CON transitioned from chambers 1-2 significantly less
than both LNIC and HNIC. Furthermore, LNIC transitioned from chambers 1-2 significantly
more than HNIC. LNIC transitioned from chambers 2-1 significantly more than both CON and
HNIC. CON transitioned from chambers 2-3 and chambers 3-2 significantly less than both LNIC
and HNIC. CON transitioned from chambers 2-4, 4-2, 4-5, 5-4, 4-6, and 6-4 significantly less
than LNIC, but not HNIC. These results suggests that nicotine at a lower dose (16.25µM)
increases larvae tendency to transition from chamber to chamber, while a higher dose of nicotine
(48.75µM) also increases chamber transitions, does so less than the lower dose. The pattern of
the data suggests that larvae treated with nicotine are more likely to transition to the other half of
the testing chamber than controls.
4.5C Chamber Transitions over Time
Overall chamber
transitions were
analyzed over 5 minute
bins for 15 minutes (see
fig 25). Five minute
bins were chosen over
one minute bins because
within one-minute bins,
Figure 25 Chamber Transitions over time, data points represent overall chamber
transitions at 5-min bins (total 15 mins) represented as means±SEM

there were not enough
chamber transitions
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made across all groups, thus skewing the data. 5-minute time bins was the minimum amount of
time that ensured homogeneity of variances. A mixed ANOVA revealed a significant effect of
condition F(2,146)=19.38, p<0.05. This effect was such that CON (0.28±0.03) larvae
transitioned significantly less than both LNIC (0.57±0.02) and HNIC (0.36±0.01) larvae, p<0.05
and p=0.002, respectively. Furthermore, LNIC larvae transitioned significantly more than HNIC
larvae, p=0.009. There was also a significant interaction of time and condition F(4,292)=2.415,
p=0.049. Simple effects test further analyzed this interaction and found that within the five
minutes, CON (0.45±0.377) larvae transitioned significantly less than LNIC (3.06±0.374) and
HNIC (2.40±0.374) larvae. Within the last five minutes, LNIC larvae (2.40±0.27) transitioned
significantly more than CON (0.78±0.27) larvae, p=0.001. HNIC (1.40±0.27) larvae did not
show any difference in transition frequency than CON, but did transition less than LNIC.
There was no significant change in frequency of transitions in CON or LNIC larvae from
the first five minutes to the last five minutes. HNIC larvae transitioned significantly less within
the last five minutes than the first five minutes of the trial, p=0.023.
4.5D Summary of Chamber Transitions
These results demonstrate that both LNIC and HNIC increased chamber transition
frequency relative to CON. Furthermore, LNIC and HNIC larvae transitioned significantly more
relative to CON across all chambers. The frequency of zone transitions did not change
significantly over the duration of the trial in CON and LNIC larvae, but significantly decreased
in HNIC larvae. Furthermore, both LNIC and HNIC larvae transitioned more than CON within
the first 5 minutes of the trial, and that LNIC larvae transitioned more than CON and HNIC
larvae in the last 5 minutes of the trial.
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4.6 Latency to Center
Latency to enter the center zone was measured both overall and between chambers 1-3
and 4-6. The reason for analyzing latency between chambers 1-3 and 4-6 is because there were
not enough occurrences of center zone entry to measure the latency changes over one minute
bins, so examining the differences between chambers 1-3 and 4-6 are to provide an estimate of
difference in time, as larvae in all treatment conditions generally did not enter the 4-6 chambers
until the latter half of the trial.
4.6A Overall Latency to Center
Overall latency to enter the
center zone was measured
averaged across all chambers
within the testing arena for each
treatment condition (see fig 26).
An ANOVA revealed that
nicotine treatment had a
Figure 26 Latency to enter center zone averaged across each chamber. Bars
represent mean±SEM

significant effect on latency to
enter the center zone

F(2,147)=5.825, p=0.004. This effect was such that both LNIC (11.42±1.11) and HNIC
(10.29±0.99) larvae exhibited a shorter latency to enter the center zone than CON (14.98±0.89)
larvae, p=0.037 and p=0.004, respectively. There was no observed difference in latency to enter
the center between the two nicotine treated groups. These results suggest that nicotine treatment
reduced the latency for the larvae to enter the center of the chamber.
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4.6B Latency to Center: Between Chambers
Latency to enter the center zone within two sets of chambers, 1-3 and 4-6, was analyzed
in order to estimate how latency to enter the center zone changed over time. Typically, larvae,
independent of treatment, would transition to chambers 4-6 during the latter half of the trial
compared to the chambers 1-3. (see fig 27). An ANOVA revealed that within chambers 1-3 there
was a significant effect of nicotine treatment on latency to enter the center zone F(2,146)=4.26,
p=0.016. This effect was such that HNIC larvae (10.22±1.06) had a significantly shorter latency
to enter the center zone than
CON (14.6±0.925) larvae.
LNIC (12.13±1.16) larvae did
not significantly differ from
either HNIC or CON.
Furthermore, latency to enter
chambers 4-6 was significantly
affected by nicotine treatment
Figure 27 Latency to enter the center zone in chambers 1-3 and chambers 4-6,
“*” indicate significance at the p=0.05 level, ns indicates non-significance. Bars
are represented as mean±SEM

F(2,49)=7.32, p=0.002. Both
LNIC (4.86±1.04) and HNIC

(5.99±1.6) larvae had a significantly shorter latency to enter the center zone than CON
(14.79±3.52), p=0.001 and p=0.009, respectively. There was no observed difference between the
two nicotine treatment groups. Student’s t-test revealed that there was no significant difference in
the CON’s latency to enter the center zone between the chambers 1-3 (9.55±1.65) and the
chambers 4-6 (14.79±3.52). There was a significant difference in latency to enter the center in
LNIC larvae within the chambers 1-3 (8.29±1.22) and 4-6 (4.869±1.04), t(24)=2.57, p=0.017.
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Lastly, there was no significant difference in the HNIC larvae in the chambers 1-3 (6.19±1.52)
and 4-6 (5.44±1.62). These results suggest that LNIC reduces latency to enter the center zone,
but is not reduced after treatment of HNIC.
4.6C Summary of Latency to Center
These results suggest that nicotine treatment had a significant effect on the latency to
enter the center zone in larvae. Specifically, within the chambers further away from the initial
chamber that the larvae were placed in, LNIC and HNIC larvae demonstrated a significant
decrease in latency to enter the center relative to chambers 1-3, while CON did not show a
difference in latency to enter the center zone.
Discussion
5.1 Interpretation of Present Results
Overall these results demonstrate that the novel 6-chamber complex environment can be
used to evaluate a wide variety of larval zebrafish behavior and has potential use for examining
behavioral phenotypes expression due to acute drug exposure, including but not limited to,
general locomotor activity, thigmotaxis and thigmotaxis types, latency to enter zones, chamber
transitions. The novelty of this testing apparatus is the ability to measure chamber transitions
within a 6-chamber complex environment, this can allow for the analysis of not only overall
effects of drugs on exploratory behavior, but also time-dependent drug responses. Furthermore,
this testing apparatus accounts for possible biases in turning behavior as the left and right
environments are mirror images of each other. Furthermore, this testing apparatus accounts for
vertical movement to some extent because in order to transition to a different chamber, larvae
have to reach a swim up a 7mm above from the bottom of the chamber. This is more valuable
than studying an animal within a single well or chamber because it provides a more complex
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analysis of behavior and reduces the likelihood of mistakenly labeling behaviors (i.e. labeling
increased exploratory behavior as reduction in anxiety). Furthermore, this novel environment is
capable of examining the larval zebrafish response to repeated novelty within a single trial, as
each chamber that the larvae may transition to is different from the one it previously occupied.
The ability to measure myriad behavioral endpoints with the 6-chamber complex environment
coupled with appropriate drug dosing procedure opens the possibility of a powerful tool for drug
screening and further analysis of the effects of drugs on behavior. This study demonstrated that
the effects of acute nicotine on larval zebrafish are complex and behavioral complexities not
previously reported in larval zebrafish.
Across most behavioral endpoints used in this study, nicotine treated larvae exhibited a
dose-dependent behavioral response as seen in previous studies in larval zebrafish (Petzold et al.
2009). Furthermore, larval zebrafish exhibit an innate preference for the outer zone of a chamber
when placed in a novel environment (Steenbergen et al. 2012). LNIC increased thigmotaxis
significantly more relative to both HNIC and CON both overall and within some chambers of the
testing apparatus. However, within some specific chambers, HNIC reduced thigmotaxic behavior
in the larvae relative to both CON and LNIC. Furthermore LNIC larvae engaged in more active
and weakly active thigmotaxic behavior than both CON and HNIC. Although HNIC also
exhibited more weakly active thigmotaxis than CON larvae, this may be due to the effect of
nicotine on exploratory behavior, as both HNIC and LNIC larvae transitioned to different
chambers more than CON larvae. This suggests that while LNIC elicits an anxiogenic HNIC
elicits an anxiolytic response. In light of the increase of locomotor activity in both nicotine
treated groups, the differential changes in thigmotaxic behavior due to LNIC and HNIC cannot
be attributed to a difference in general locomotor activity. By using distance moved and time
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spent measures of thigmotaxis, changes in thigmotaxic behavior across all three conditions
cannot be attributed to increase in general locomotor activity as the effects of nicotine treatment
on the two measures of thigmotaxis were generally conserved.
Nevertheless, nicotine treatment increased locomotor activity early on in the trial, but
then began to decrease throughout the duration of the trial. In this case, the LNIC demonstrated a
decrease in locomotor activity by the last minute of the trial while the HNIC maintained a more
locomotor activity than both the CON and LNIC larvae. This suggests that the HNIC motivated
more locomotor activity than LNIC. However, this result is further complicated when looking at
the chamber transition results.
Larvae treated with LNIC demonstrated an increased amount of transitions than both the
CON and HNIC. These results fit in with the discrepancies between the LNIC and HNIC general
locomotor activity when viewed in the context of thigmotaxic behavior. As LNIC not only
exhibited more thigmotaxis, but also more active and weakly active thigmotaxis than both CON
and HNIC, LNIC larvae would demonstrate more transitions as they were following the wall
more tightly than the egg water treated or the higher dose nicotine treated, therefore reducing the
time that they spent in the center well and increasing the probability of transitioning to a different
chamber.
Previous literature has demonstrated that thigmotaxis is a valid measure of anxiety-driven
behavior such that increased thigmotaxis demonstrates increased anxiety while decreased
thigmotaxis demonstrates decreased anxiety. Furthermore, studies have shown that nicotine
reduces anxiety in adult zebrafish (Levin et al. 2007). However, the data from this study suggests
that LNIC caused an increased in thigmotaxis. Therefore, this data would suggest that LNIC
increases anxiety. While this may be the case, it is also possible that thigmotaxis is not as a
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reliable measure of anxiety in larval zebrafish. This assertion substantiated is by the latency to
enter the center one arena.
The reason for why thigmotaxic behavior is a marker of anxiety is based on that an
animal, when in the center of a space, is more open to predation and other forms of harm,
therefore the animal moves towards the borders of its environment to attempt to escape harm.
When given an anxiolytic drug such as diazepam or other anxiolytics commonly prescribed to
humans, the animal is more likely to move and spend time in the center of their environment.
While the LNIC larvae demonstrated higher thigmotaxis than CON and HNIC, both LNIC and
HNIC larvae exhibited a shorter latency to enter the center zone than the CON. This suggests
that when first entering a chamber, larvae treated with nicotine are quicker to enter the center
zone than control fish. While this may be attributed to a general increase in locomotor activity,
when examining the between chamber differences (1-3 as opposed to 4-6), the latency to enter
the center zone of the LNIC and HNIC larvae significantly decreased when in chambers 4-6 than
1-3, while CON exhibited the same latency to enter the center zone in chambers 1-3 as 4-6. This
suggests that nicotine treated larvae were more willing to enter the center zone of a new
environment than controls, potentially demonstrating a reduction in anxiety, in spite of increased
thigmotaxis.
The motivation behind analyzing the differences in latency between chambers 1-3 and
chambers 4-6 was to estimate whether there was an effect of time on latency to transition.
Assuming that latency within chambers 1-3 represented the latency within the first half of the
trial, while latency within chambers 4-6 represented the latter half of the trial, then there is a
time-dependent effect of nicotine on the latency to enter the center zone in larval zebrafish. The
evidence for a time-dependent effect is supported by the time by condition interactions observed
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in both the general locomotor activity and chamber transition time binned data. Another
explanation for the observed effect of time is that nicotine reduced the larval zebrafish reaction
to novelty. As chambers 1-3 include the initial chamber that the larvae are placed into, and
chambers 4-6 are entirely novel chambers, it is possible that both LNIC and HNIC cause the
larvae to be less fearful of novel environments.
Another way of interpreting the present results is by distinguishing between anxiolytic
and exploratory behavior. LNIC larvae demonstrated increased locomotor activity, thigmotaxis,
active thigmotaxis path taking, chamber transitions, and decreased latency to enter the center far
away chambers. Together, these results suggest that LNIC increases exploratory behavior, but
does not affect anxiety. In comparison, HNIC larvae demonstrated increase locomotor activity,
slight decrease in thigmotaxis, no increase in active thigmotaxis path taking, increased chamber
transitions, and decreased latency to enter the center of far away chambers. This suggests that
HNIC increases exploratory behavior, but has anxiolytic effect on zebrafish larvae. Furthermore,
as nicotinic receptors are mainly located on dopaminergic neurons, it is possible that nicotine
mainly effects locomotor behavior, this would be evidence by this study because both low dose
and high dose nicotine treated larvae exhibited and increase in locomotor behavior relative to the
CON. Nicotine has been shown to have some effect on serotonin, but it has been unclear whether
the effect is downstream of the primary activation of nicotinic receptors, or if there are nicotinic
receptors on serotonergic neurons. In the former case, it is possible that the increase in
exploratory behavior followed by the reinforcement that no harm is occurring causes a change in
serotonin levels, while in the latter case nicotine would have a direct impact on the modulation of
serotonin thereby expressing a direct effect on serotonin-mediated behaviors such as anxiety. As

EFFECTS OF ACUTE NICOTINE ON LARVAL ZEBRAFISH

48

the commonly prescribed drugs for pathological anxiety are compounds that mainly affect
serotonin levels, it is unclear the mechanism that nicotine reduces anxiety—even in humans.
5.2 Limitations and Future Directions
During the execution of this study it was difficult to test the larvae at the same time of
day, which may have affected the locomotor behavior of the larvae, as they tend to be more
active during the early morning than in the afternoon (MacPhail et al. 2009). Furthermore, a
reoccurring issue during this experiment was that for CON larvae, not enough subjects would
enter the farther away cambers (chambers 4-6); therefore future modifications of this complex
environment might employ 3 chambers rather than 6. Due to time issues, this experiment was
unable to report the effects of nicotinic receptor antagonist, mecamylamine, on the behavioral
endpoints measured in this study. Preliminary observations suggest that mecamylamine
attenuates the nicotine-induced behaviors of high dose nicotine (not yet tested in low-dose
nicotine). The use of nicotinic receptor antagonists may enable further characterization of
exploratory versus anxiety-related behaviors. Future studies using the 6-chamber complex
environment can combine different anxiety-based assays, such as the light-dark test to further
examine behavioral phenotypes associated with anxiety, therefore removing the reliance on
thigmotaxis and other common behavioral traits to demonstrate anxiety-driven behavior.
Furthermore, in order to fully evaluate the utility of this 6-chamber complex environment for
future behavioral testing, other compounds, perhaps better understand drugs need to be tested
and compared to previous studies to see whether the behavioral changes are consistent. One
possibility for examining anxiety-driven behavior is using an anxiogenic such as caffeine, and a
commonly prescribed anxiolytic such as diazepam. Although it would be interesting to
investigate fluoxetine, another commonly prescribed anxiolytic, that has been shown to be
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efficacious in treating pathological anxiety, but has been confounded within the literature as the
current behavioral assays available are unable to detect an anxiolytic effect of fluoxetine on their
subjects using the common behavioral endpoints such as thigmotaxis. To further understand the
cellular and molecular differences of nicotine, it would be interesting to quantify the
neurotransmitters—GABA, dopamine, and serotonin—as well as their metabolites to see
whether there are differences in neurotransmitter levels that can be attributed to specific doses of
nicotine. Furthermore, if the 6-chamber complex environment is used to determine behavioral
phenotypes that are linked to the desensitization of a nicotinic receptor, quantifying the
neurotransmitter levels may give an idea as to on what type of neuron the desensitization is
occurring. In regards to the desensitization of nAChRs is that it is possible that the methodology
used in this study, immersion rather than knockout procedure allowed for the desensitization of
nicotine, which can partially explain the time dependent effects of nicotine. A study that would
examine how larval zebrafish exposed to a wash-out treatment schedule would be interesting to
see if the same time-dependent effects of nicotine on general locomotor activity and latency to
enter the center of the arena would be observed.
Nicotine plays a complicated role at the cellular level of nicotinic receptors. While it was
previously thought that activation of these receptors by nicotine is the reason for the observed
behavioral (addiction) and affective (anxiety) changes, recent research has suggested that these
behavioral and affective changes can be attributed to the desensitization of nicotinic receptors by
nicotine. One study found that rats exhibited anxiolytic behavior after a low dose administration
of nicotine, and showed that the desensitization of the β2 subunit of the nicotinic receptors found
within the ventral tegmental area and nucleus accumbens was responsible for this change in
anxiety-driven behavior, while activation of the nicotinic receptors contributed to the observed
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addiction (Anderson & Brunzell 2012). It is not yet clear the relationship between dose strength
and extent of desensitization, but this research demonstrates, that the effect of nicotine is not
clear-cut due to its ability to quickly desensitize nicotinic receptors.
The results of this experiment demonstrate not only dose-dependent behavioral changes
due to nicotine, but also results that are inconsistent with the current literature on anxiety-driven
behavior in rodents and adult zebrafish. While these inconsistent observations may be due to
intrinsic properties of larval zebrafish behavioral phenotypes and possibly molecular and cellular
differences in nicotinic receptor function, they can still be resolved by examining the data within
the context of other behavioral endpoints that were measured in this study. This study suggests
that the larval zebrafish has a vast repertoire of behavioral phenotypes that have not yet been
explored due to the limitations of current behavioral assays, but also the effect of different
nicotine doses on the aforementioned behaviors. The move towards the characterization of more
complex behaviors in larval zebrafish is especially important as the use of nicotine products
rises. The 6-chamber complex environment provides a novel behavioral assay to further
understand the effects of nicotine on behavior and has the potential to be used for the screening
of novel drugs in larval zebrafish.
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